Safe Direct Current Stimulator (SDCS) technology for blocking chronicperipheral pain

用于缓解慢性外周疼痛的安全直流刺激器 (SDCS) 技术

基本信息

  • 批准号:
    10408687
  • 负责人:
  • 金额:
    $ 53.84万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-04-15 至 2024-04-14
  • 项目状态:
    已结题

项目摘要

Project Summary The central goal of this project is to advance the therapeutic applications and the potential for using ionic direct current to interact with the nervous system. Direct current (DC) compared to biphasic charge balanced pulses normally used by neural prostheses to interface to the nervous system, can more naturally control neural activity. Unlike biphasic current pulses used to excite neurons, DC can excite, inhibit, and modulate sensitivity of neurons. While DC can be used for short durations to interact with the nervous system, chronic use of this stimulation paradigm for implantable prosthetic applications has not been possible due to the DC’s inherent violation of the charge injection safety constraints at the metal electrode interfaces. New technology, safe direct current stimulation (SDCS) overcomes these constraints and opens an additional avenue for research into exciting possibilities of using DC to interface to the nervous system. We will optimize the use of ionic DC to improve the performance of chronic pain suppression. Chronic pain suppression requires inhibiting pain carrying neurons from conducting action potentials. We obtained preliminary data in an anesthetized rat model showing that safe DC neural block at the sciatic nerve could suppress pain signals from propagating to the spinal cord, but allow normal propagation of sensation and muscle movement. Here we propose to understand the mechanism behind safe DC modulation of pain signals through anesthetized mouse and rat experiments. We will conduct the behavioral experiments to understand the effectiveness of this technology for addressing chronic pain in an awake animal. We will also conduct histological studies to investigate the biological impact of the therapy. Finally, we will advance the SDCS technology by identifying and solving the key technical challenges with a miniaturized and implantable SDCS. Aim 1. Examine the mechanism of the iDC effect on suppression of nociceptive pain. Aim 2. Examine the effects and underlying mechanisms of iDC on neuropathic pain signals. Aim 3. Behavioral experiments to study iDC for inhibition of neuropathic pain. Aim 4. Implantable SDCS technology development.
项目摘要 该项目的中心目标是促进离子药物的治疗应用和潜力。 直流电与神经系统相互作用。直流电(DC)与两相平衡电荷的比较 神经假体通常用来连接神经系统的脉冲可以更自然地控制神经 活动。与用于兴奋神经元的两相电流脉冲不同,DC可以兴奋、抑制和调节灵敏度 神经细胞的。虽然DC可以在短时间内与神经系统相互作用,但长期使用这种药物 由于DC的固有特性,用于植入性假体应用的刺激范例是不可能的 违反金属电极界面处的电荷注入安全约束。新技术,安全直接 电流刺激(SDC)克服了这些限制,并开辟了另一条研究途径 使用DC连接神经系统的令人兴奋的可能性。 我们将优化使用离子DC,以提高慢性疼痛抑制的性能。慢性 疼痛抑制需要抑制携带疼痛的神经元传导动作电位。我们获得了 麻醉大鼠模型的初步数据显示,安全的DC神经阻滞在坐骨神经可以 抑制疼痛信号传播到脊髓,但允许感觉和肌肉的正常传播 有动静。 在这里,我们建议通过以下方式来理解疼痛信号安全直流调制背后的机制 麻醉小鼠和大鼠实验。我们将进行行为实验,以了解 这项技术对解决清醒动物慢性疼痛的有效性。我们还将进行组织学研究 研究以调查该疗法的生物学影响。最后,我们将通过以下方式推进SDCS技术 利用小型化和可植入的SDCS识别和解决关键技术挑战。 目的1.研究IDC抑制伤害性疼痛的机制。 目的2.研究IDC对神经病理性疼痛信号的影响及其机制。 目的3.行为实验研究IDC对神经病理性疼痛的抑制作用。 目的4.植入型SDCS技术开发。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gene Yevgeny Fridman其他文献

Gene Yevgeny Fridman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gene Yevgeny Fridman', 18)}}的其他基金

Safe Direct Current Stimulator (SDCS) technology for blocking chronic peripheral pain
用于缓解慢性外周疼痛的安全直流刺激器 (SDCS) 技术
  • 批准号:
    9885600
  • 财政年份:
    2020
  • 资助金额:
    $ 53.84万
  • 项目类别:
Safe Direct Current Stimulator (SDCS) technology for blocking chronicperipheral pain
用于缓解慢性外周疼痛的安全直流刺激器 (SDCS) 技术
  • 批准号:
    10610959
  • 财政年份:
    2020
  • 资助金额:
    $ 53.84万
  • 项目类别:
Safe Direct Current for Neuroprosthetic Applications
用于神经修复应用的安全直流电
  • 批准号:
    9765416
  • 财政年份:
    2015
  • 资助金额:
    $ 53.84万
  • 项目类别:
Safe Direct Current for Neuroprosthetic Applications
用于神经修复应用的安全直流电
  • 批准号:
    9052334
  • 财政年份:
    2015
  • 资助金额:
    $ 53.84万
  • 项目类别:
Safe Direct Current Neural Stimulation System
安全直流神经刺激系统
  • 批准号:
    8509551
  • 财政年份:
    2013
  • 资助金额:
    $ 53.84万
  • 项目类别:
Stimulation model and experiments for a vestubular prosthesis.
前庭假体的刺激模型和实验。
  • 批准号:
    7614826
  • 财政年份:
    2008
  • 资助金额:
    $ 53.84万
  • 项目类别:
Stimulation model and experiments for a vestubular prosthesis.
前庭假体的刺激模型和实验。
  • 批准号:
    7673322
  • 财政年份:
    2008
  • 资助金额:
    $ 53.84万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 53.84万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.84万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 53.84万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.84万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 53.84万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.84万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 53.84万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 53.84万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 53.84万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.84万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了